Abstract
The adenovirus E1A protein has been implicated in increasing cellular susceptibility to apoptosis induced by tumor necrosis factor (TNF); however, its mechanism of action is still unknown. Since activation of nuclear factor kappaB (NF-kappaB) has been shown to play an anti-apoptotic role in TNF-induced apoptosis, we examined apoptotic susceptibility and NF-kappaB activation induced by TNF in the E1A transfectants and their parental cells. Here, we reported that E1A inhibited activation of NF-kappaB and rendered cells more sensitive to TNF-induced apoptosis. We further showed that this inhibition was through suppression of IkappaB kinase (IKK) activity and IkappaB phosphorylation. Moreover, deletion of the p300 and Rb binding domains of E1A abolished its function in blocking IKK activity and IkappaB phosphorylation, suggesting that these domains are essential for the E1A function in down-regulating IKK activity and NF-kappaB signaling. However, the role of E1A in inhibiting IKK activity might be indirect. Nevertheless, our results suggest that inhibition of IKK activity by E1A is an important mechanism for the E1A-mediated sensitization of TNF-induced apoptosis.
Highlights
The adenovirus E1A protein has been implicated in increasing cellular susceptibility to apoptosis induced by tumor necrosis factor (TNF); its mechanism of action is still unknown
This is consistent with the previous finding that the E1A function in increasing cellular susceptibility to cell death induced by TNF depends on its binding to either p300 or p105Rb [10]
We examined the expression of E1A in these cell lines by Western blot analysis using an anti-E1A monoclonal antibody (M58)
Summary
The adenovirus E1A protein has been implicated in increasing cellular susceptibility to apoptosis induced by tumor necrosis factor (TNF); its mechanism of action is still unknown. When the cells were transiently transfected with the luciferase reporter gene (pCMV-luc) and treated with TNF, the luciferase activity was strongly reduced in the ip1-E1A2 cells compared with the parental SKOV3.ip1 and the mutant ip1-Efs cells (Fig. 1A). We examined the expression of E1A in these cell lines (ip1-E1A2, ip1-Efs, SKOV3.ip1, and Edl.0108/ ip1) by Western blot analysis using an anti-E1A monoclonal antibody (mAb) (M58).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.